The U.S. Food and Drug Administration has outlined its budget and legislative proposals for 2025, with the only dedicated section concerning dietary supplements renewing calls for mandatory product listing and seeking clarifications on the Agency's authorities.
FDA last week published a guidance document on a notification requirement in DSHEA that is perhaps more important than ever in the law's 30-year history.
ChromaDex CEO Rob Fried advocates for the formation of a new group "consisting of industry players endeavoring to be righteous in their practices."
A study that compares the label accuracy of a generic drug versus a dietary supplement with the same active ingredient found that the supplement fared very poorly when stacked up against the prescription version.
A study that compares the label accuracy of a generic drug versus a dietary supplement with the same active ingredient found that the supplement fared very poorly when stacked up against the prescription version.